Review of plasma exchange and rituximab for prevention of recurrent focal segmental glomerulosclerosis after a prior graft loss

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

375

Figures (1-1)

Tables (1-3)

Sum=472

Publishing Process of This Article

Item

Count

Browse

Download

Sum=43

Dec 18, 2024 (publication date) through Oct 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Transplant. Dec 18, 2024; 14(4): 98155
Published online Dec 18, 2024. doi: 10.5500/wjt.v14.i4.98155

Table 2 Rates of recurrence following prophylactic use of plasma exchange or rituximab

PE: Plasma exchange; RTX: Rituximab.

Citation: Gharaei S, Abbas H, Kanigicherla DA. Review of plasma exchange and rituximab for prevention of recurrent focal segmental glomerulosclerosis after a prior graft loss. World J Transplant 2024; 14(4): 98155
URL: https://www.wjgnet.com/2220-3230/full/v14/i4/98155.htm
DOI: https://dx.doi.org/10.5500/wjt.v14.i4.98155